Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 14;12(1):4371.
doi: 10.1038/s41598-022-08491-8.

Hospitalization rates from radiotherapy complications in the United States

Affiliations

Hospitalization rates from radiotherapy complications in the United States

Raees Tonse et al. Sci Rep. .

Abstract

Hospitalizations due to radiotherapy (RT) complications result in significant healthcare expenditures and adversely affect the quality of life of cancer patients. Using a nationally representative dataset, the objective of this study is to identify trends in the incidence of these hospitalizations, their causes, and the resulting financial burden. Data from the National Inpatient Sample was retrospectively analyzed from 2005 to 2016. RT complications were identified using ICD-9 and ICD-10 external cause-of-injury codes. The hospitalization rate was the primary endpoint, with cost and in-hospital death as secondary outcomes. 443,222,223 weighted hospitalizations occurred during the study period, of which 482,525 (0.11%) were attributed to RT. The 3 most common reasons for RT-related hospitalization were cystitis (4.8%, standard error [SE] = 0.09), gastroenteritis/colitis (3.7%, SE = 0.07), and esophagitis (3.5%, SE = 0.07). Aspiration pneumonitis (1.4-fold) and mucositis (1.3-fold) had the highest relative increases among these hospitalizations from 2005 to 2016, while esophagitis (0.58-fold) and disorders of the rectum and anus were the lowest (0.67-fold). The median length of stay of patient for hospitalization for RT complications was 4.1 (IQR, 2.2-7.5) days and the median charge per patient was $10,097 (IQR, 5755-18,891) and the total cost during the study period was $4.9 billion. Hospitalization for RT-related complications is relatively rare, but those that are admitted incur a substantial cost. Use of advanced RT techniques should be employed whenever possible to mitigate the risk of severe toxicity and therefore reduce the need to admit patients.

PubMed Disclaimer

Conflict of interest statement

R. Tonse, M. Rubens, V. Ramamoorthy, A. Saxena, E. Veledar, P. McGranaghan: None. M. Hall: Honorarium from Accuray, Inc. Proton Collaborative Group Executive Committee Institutional Representative and Voting Member, Miami Cancer Institute (unpaid). Grant Funding: Live Like Bella Pediatric Cancer Research Initiative, Florida Department of Health Grant 8LA04. M. Chuong: Honorarium from Accuray, Inc., ViewRay Inc., Sirtex Inc. Advisory board for ViewRay, Inc. Research funding from ViewRay, Inc., Novocure, Inc., AstraZeneca, Inc. M. S. Ahluwalia: Receipt of grants/research supports: Astrazeneca, BMS, Bayer, Incyte, Pharmacyclics, Novocure, Mimivax, Merck. Receipt of honoraria or consultation fees: Bayer, Novocure, Kiyatec, Insightec, GSK, Nuvation, Cellularity, Apollomics. Stock shareholder: Doctible, Mimivax, Cytodyn. M. P. Mehta: Consulting for Karyopharm, Sapience, Zap, Mevion. Board of Directors: Oncoceutics. R. Kotecha: Honoraria from Accuray Inc., Elekta AB, Viewray Inc., Novocure Inc., Elsevier Inc. Institutional research funding from Medtronic Inc., Blue Earth Diagnostics Ltd., Novocure Inc., GT Medical Technologies, Astrazeneca, Exelixis, Viewray Inc.

Figures

Figure 1
Figure 1
Percentage of patients admitted for RT related complications by most common cancer types.
Figure 2
Figure 2
Relative change in number of hospitalizations for radiation cystitis, radiation-induced lung injury, aspiration pneumonitis, esophagitis, and disorders of rectum and anus, intestinal obstruction, radiation-induced gastroenteritis and colitis, gastrointestinal tract hemorrhage, stricture and stenosis of esophagus, and mucositis from 2006 to 2015.

Similar articles

Cited by

References

    1. Cancer Statistics, https://www.cancer.gov/about-cancer/understanding/statistics.
    1. Cheng M, Jolly S, Quarshie WO, Kapadia N, Vigneau FD. Modern radiation further improves survival in non-small cell lung cancer: An analysis of 288,670 patients. J. Cancer. 2019;10:168. doi: 10.7150/jca.26600. - DOI - PMC - PubMed
    1. Palumbo MO, et al. Systemic cancer therapy: Achievements and challenges that lie ahead. Front. Pharmacol. 2013;4:57. doi: 10.3389/fphar.2013.00057. - DOI - PMC - PubMed
    1. Halpern MT, Yabroff KR. Prevalence of outpatient cancer treatment in the United States: Estimates from the Medical Panel Expenditures Survey (MEPS) Cancer Investig. 2008;26:647–651. doi: 10.1080/07357900801905519. - DOI - PubMed
    1. Du XL, Osborne C, Goodwin JS. Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. J. Clin. Oncol. 2002;20:4636. doi: 10.1200/JCO.2002.05.088. - DOI - PMC - PubMed